Ken Griffin
BFRIW icon

Ken Griffin’s Biofrontera BFRIW Stock Holding History

Ken Griffin’s Portfolio BFRIW Stock Details BFRIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-11,617
Closed -$465 – 14252
2024
Q2 		$465 Buy
11,617
+950
+9% +$49 ﹤0.01% 13986
2024
Q1 		$374 Buy
+10,667
New +$314 ﹤0.01% 14349

Other funds holding BFRIW

BA
Bard Associates Chicago, Illinois $451M AUM 66.6% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $91.6B AUM 29.2% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ken Griffin's BFRIW Position: Q3 2024 in Review

Ken Griffin sold out of Biofrontera (BFRIW) in Q3 2024, closing a stake of 11,617 shares — an estimated $465 sold.

Ken Griffin first reported a position in BFRIW in Q1 2024 and held it in 2 quarters. The position peaked at $465 in Q2 2024. 6 funds tracked by Wall St. Rank hold BFRIW as of Q3 2024.

  • Ken Griffin reported no remaining Biofrontera position as of Q3 2024 after selling out during the quarter.
  • Ken Griffin sold 11,617 Biofrontera shares in Q3 2024, an estimated $465.
  • Ken Griffin first reported a position in Biofrontera in Q1 2024 and held it in 2 quarters.
  • Ken Griffin's Biofrontera position peaked at $465 in Q2 2024.
  • 6 funds tracked by Wall St. Rank held Biofrontera as of Q3 2024.

Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.